Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308977453> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4308977453 endingPage "vii84" @default.
- W4308977453 startingPage "vii83" @default.
- W4308977453 abstract "Abstract Glioblastoma (GBM) is the most common and aggressive primary brain tumor. External beam radiation therapy (EBRT) is widely recognized as an effective treatment for primary GBM. EBRT applied after GBM resection is associated with an increase in overall survival. Beyond upfront therapy with radiation and temozolomide chemotherapy, there is no standard therapy that has been proven effective. Re-irradiation with ERBT is minimally effective and with significant comorbidities. Our study uses IORT at the time of re-resection in patients who have recurrent, operable GBM after failure of who received primary EBRT and temozolamide in their first course of treatment. IORT allows the delivery of a large effective radiation dose applied directly to the tumor bed at the time of resection. This affords direct radiation to be delivered to the micro- and macroscopic tumor remnants in the vicinity of the resection cavity immediately following gross resection. In contrast, the more distant, surrounding brain tissue does not receive high radiation exposure. This Phase II study continues to accrue subjects with the primary endpoint of overall survival and several secondary endpoints that includes progression free survival, quality of life, and adverse events/safety. To date, five patients have been treated on this protocol. The technical feasibility and safety of administering intraoperative radiation with the Xoft System has been established in this cohort. Preliminary GLIOX Trial findings demonstrate the safety and feasibility of using the Xoft Axxent® Electronic Brachytherapy System to administer intracranial radiation during resection of recurrent glioblastomas. We will report new and expansive study results to include these early findings." @default.
- W4308977453 created "2022-11-20" @default.
- W4308977453 creator A5009368271 @default.
- W4308977453 creator A5031192824 @default.
- W4308977453 creator A5032504431 @default.
- W4308977453 creator A5035365137 @default.
- W4308977453 creator A5053093213 @default.
- W4308977453 creator A5057326797 @default.
- W4308977453 creator A5063863193 @default.
- W4308977453 creator A5067292024 @default.
- W4308977453 creator A5072664503 @default.
- W4308977453 creator A5085801807 @default.
- W4308977453 creator A5088509223 @default.
- W4308977453 date "2022-11-01" @default.
- W4308977453 modified "2023-09-25" @default.
- W4308977453 title "CTNI-51. FEASIBILITY AND SAFETY OF NEUROSURGICAL RESECTION AND INTRA-OPERATIVE RADIATION THERAPY USING THE XOFT AXXENT ELECTRONIC BRACHYTHERAPY SYSTEM AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA" @default.
- W4308977453 doi "https://doi.org/10.1093/neuonc/noac209.316" @default.
- W4308977453 hasPublicationYear "2022" @default.
- W4308977453 type Work @default.
- W4308977453 citedByCount "0" @default.
- W4308977453 crossrefType "journal-article" @default.
- W4308977453 hasAuthorship W4308977453A5009368271 @default.
- W4308977453 hasAuthorship W4308977453A5031192824 @default.
- W4308977453 hasAuthorship W4308977453A5032504431 @default.
- W4308977453 hasAuthorship W4308977453A5035365137 @default.
- W4308977453 hasAuthorship W4308977453A5053093213 @default.
- W4308977453 hasAuthorship W4308977453A5057326797 @default.
- W4308977453 hasAuthorship W4308977453A5063863193 @default.
- W4308977453 hasAuthorship W4308977453A5067292024 @default.
- W4308977453 hasAuthorship W4308977453A5072664503 @default.
- W4308977453 hasAuthorship W4308977453A5085801807 @default.
- W4308977453 hasAuthorship W4308977453A5088509223 @default.
- W4308977453 hasBestOaLocation W43089774531 @default.
- W4308977453 hasConcept C126322002 @default.
- W4308977453 hasConcept C126838900 @default.
- W4308977453 hasConcept C141071460 @default.
- W4308977453 hasConcept C143998085 @default.
- W4308977453 hasConcept C203092338 @default.
- W4308977453 hasConcept C2775908122 @default.
- W4308977453 hasConcept C2776694085 @default.
- W4308977453 hasConcept C2777389519 @default.
- W4308977453 hasConcept C2777416452 @default.
- W4308977453 hasConcept C2777802072 @default.
- W4308977453 hasConcept C509974204 @default.
- W4308977453 hasConcept C535046627 @default.
- W4308977453 hasConcept C71924100 @default.
- W4308977453 hasConceptScore W4308977453C126322002 @default.
- W4308977453 hasConceptScore W4308977453C126838900 @default.
- W4308977453 hasConceptScore W4308977453C141071460 @default.
- W4308977453 hasConceptScore W4308977453C143998085 @default.
- W4308977453 hasConceptScore W4308977453C203092338 @default.
- W4308977453 hasConceptScore W4308977453C2775908122 @default.
- W4308977453 hasConceptScore W4308977453C2776694085 @default.
- W4308977453 hasConceptScore W4308977453C2777389519 @default.
- W4308977453 hasConceptScore W4308977453C2777416452 @default.
- W4308977453 hasConceptScore W4308977453C2777802072 @default.
- W4308977453 hasConceptScore W4308977453C509974204 @default.
- W4308977453 hasConceptScore W4308977453C535046627 @default.
- W4308977453 hasConceptScore W4308977453C71924100 @default.
- W4308977453 hasIssue "Supplement_7" @default.
- W4308977453 hasLocation W43089774531 @default.
- W4308977453 hasOpenAccess W4308977453 @default.
- W4308977453 hasPrimaryLocation W43089774531 @default.
- W4308977453 hasRelatedWork W1986331770 @default.
- W4308977453 hasRelatedWork W2107163829 @default.
- W4308977453 hasRelatedWork W2110966639 @default.
- W4308977453 hasRelatedWork W2462822954 @default.
- W4308977453 hasRelatedWork W2536552580 @default.
- W4308977453 hasRelatedWork W2545627348 @default.
- W4308977453 hasRelatedWork W2566967253 @default.
- W4308977453 hasRelatedWork W3085345277 @default.
- W4308977453 hasRelatedWork W4206581437 @default.
- W4308977453 hasRelatedWork W4295758394 @default.
- W4308977453 hasVolume "24" @default.
- W4308977453 isParatext "false" @default.
- W4308977453 isRetracted "false" @default.
- W4308977453 workType "article" @default.